Naproxen Sodium/Diphenhydramine Hydrochloride

่˜ๆ™ฎ็”Ÿ้’ /็›้…ธ่‹ฏๆตทๆ‹‰ๆ˜Ž

Report date: 2022/09/08 15:17:13

Base Information

Drug NameNaproxen Sodium/Diphenhydramine Hydrochloride
Drug Alias NameDiphenhydramine Hydrochloride/Naproxen Sodium็›้…ธ่‹ฏๆตทๆ‹‰ๆ˜Ž/่˜ๆ™ฎ็”Ÿ้’ ่˜ๆ™ฎ็”Ÿ/่‹ฏๆตทๆ‹‰ๆ˜ŽNaproxen/diphenhydramineAleve Pm
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHistamine H1 receptor inverse agonists
TargetsHistamine H1 receptorCyclooxygenases
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/01/17
Country/TerritoryUnited StatesMainland China
CombinationsYes NaproxenDiphenhydramine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare Co Ltd
Inactive CompaniesShandong Chengchuang Pharmaceutical Technology Development Co Ltd
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05C
Related LinksWikipedia